» Without Label » Favipiravir Tabletten : Gphf Aktuelle Meldungen : List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 “undesirable effects” of smpc and section 4 “possible side effects” of package leaflet

Favipiravir Tabletten : Gphf Aktuelle Meldungen : List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 “undesirable effects” of smpc and section 4 “possible side effects” of package leaflet

–

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8
Remdesivir Avigan Und Chloroquin Wie Weit Die Corona Medikamente Sind Watson from www.watson.de
List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8
Favipiravir Doccheck Flexikon from dccdn.de
List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8
Coronavirus Behandlung Wirksame Medikamente Warnung Vor Ibuprofen from deavita.com
List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

Favipiravir Tabletten : Gphf Aktuelle Meldungen : List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet. List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 48 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet favipiravir. List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 "undesirable effects" of smpc and section 4 "possible side effects" of package leaflet